Results 41 to 50 of about 8,454 (202)

Comparative Efficacy of Rabeprazole and Pantoprazole in the Control of Nocturnal Acid Output and Intragastric Acidity

Gut and Liver, 2008
Background/Aims: Nocturnal reflux is a largely undiagnosed and unmanaged condition predisposing to multiple esophageal complications. We evaluated the effects of rabeprazole and pantoprazole on nocturnal intragastric pH and gastric acid output during Day
doaj   +1 more source

Efficacy of H. pylori eradication depending on genetic polymorphism of CYP2C19, MDR1 and IL-1β [PDF]

Терапевтический архив, 2019
Aim. To evaluate an association of genetic polymorphisms CYP2C19, MDR1, and IL-1β on the eradication rate by 10-day modified therapy in patients with H. pylori - associated diseases. Materials and methods.
N V Bakulina, I V Maev, I V Savilova, I G Bakulin, T A Il'chishina, K A Zagorodnikova, A A Murzina, D N Andreev   +7 more
doaj   +1 more source

Orthotopic Esophageal Cancer Xenograft Model in Immunosuppressed Microminipigs for Near‐Infrared Fluorescence Endoscopy

Cancer Science, EarlyView.
We report the first successful orthotopic engraftment of human esophageal squamous cell carcinoma in immunosuppressed microminipigs and demonstrate high‐contrast near‐infrared fluorescence endoscopic detection using EGFR‐targeted cetuximab. This large‐animal model bridges preclinical imaging research and future clinical translation in esophageal cancer.
Takanori Miyake, Yutaka Kawano, Takanori Kashihara, Masaki Takasu, Kentaroh Takagaki, Shota Fujimoto, Tomoyuki Kawaguchi, Kaizo Kagemoto, Yoshifumi Kida, Koichi Okamoto, Masahiro Sogabe, Naoki Muguruma, Koichi Tsuneyama, Yasushi Sato, Tetsuji Takayama   +14 more
wiley   +1 more source

Proton-pump inhibitor use is associated with a broad spectrum of neurological adverse events including impaired hearing, vision, and memory. [PDF]

, 2019
Proton-pump inhibitors, PPIs, are considered effective therapy for stomach acid suppression due to their irreversible inhibition of the hydrogen/potassium pump in the gastric parietal cells. They are widely prescribed and are considered safe for over-the-
Abagyan, Ruben, Alpatty, Sama, Atayee, Rabia S, Lee, Kelly C, Makunts, Tigran   +4 more
core   +1 more source

Gastroesophageal Reflux Disease Relief in Patients Treated with Rabeprazole 20 mg versus Omeprazole 20 mg: A Meta-Analysis

Gastroenterology Research and Practice, 2013
Background. Randomized controlled trials (RCTs) have been conducted comparing the efficacy of rabeprazole 20 mg or omeprazole 20 mg once daily for patients with erosive gastroesophageal reflux disease (GERD).
X. M. Xia, H. Wang
doaj   +1 more source

Rabeprazole

, 2006
europepmc   +2 more sources

Rationalizing Proton Pump Inhibitor Use: Southeast Asia Consensus Recommendations

Journal of Gastroenterology and Hepatology, EarlyView.
ABSTRACT Background and Aim Proton pump inhibitors (PPIs) are integral to managing many gastrointestinal conditions. However, the prevalent inappropriate PPI prescription across Southeast Asia (SEA) is concerning. Given the absence of locally tailored recommendations to inform clinical practice, this consensus document aims to provide recommendations ...
Somchai Leelakusolvong, Tju Siang Chua, Duc Trong Quach, Andrew Ming‐Liang Ong, Ari Fahrial Syam, Augusto Jose G. Galang, Wee Kooi Cheah, Hang Viet Dao, Jose D. Sollano, Kalwinder Singh Khaira, Phuripong Kijdamrongthum, Rahela Ambaras Khan, Sakkarin Chirapongsathorn, Yeong Yeh Lee   +13 more
wiley   +1 more source

Are proton pump inhibitors the first choice for acute treatment of gastric ulcers? A meta analysis of randomized clinical trials [PDF]

, 2002
Background Gastric ulcers are a frequent problem in the United States. Proton pump inhibitors have been shown to increase healing rates and improve clinical symptoms.
JH Kurata, C Florent, T Hasebe, SJ Sontag, T Hasebe, G Sachs, G Sachs, W Schepp, DL Earnest, M Robinson, OS Miettinen, DL Avner, JE Valenzuela, ML Cloud, KD Bardhan, P Michel, M Classen, Cooperative Study Group, Italian Cooperative Group on Omeprazole, A Walan, KW Choi, JP Bader, J Hotz, C Florent, L Witzel, CP Dekkers, TJ Humphries, F Di Mario, J Caro, T Poynard, CN Ulvertaft, RM Kirk, CW Howden   +32 more
core   +2 more sources

Efficacy of rabeprazole (Razo®) in the treatment of various clinical variants of GERD: results from the GERBERA study

Медицинский совет, 2022
Introduction. Gastroesophageal reflux disease (GERD) is extremely common in the structure of gastroenterological diseases. Aim. To conduct a prospective observational post-marketing study of rabeprazole (Razo®) 20 mg taking once daily in patients with ...
V. V. Tsukanov, M. A. Cherepnin, A. V. Vasyutin, J. L. Tonkikh, E. V. Kasparov, N. A. Maslennikova, N. V. Pavlova   +6 more
doaj   +1 more source

Case Report: Scar‐Like Alterations of the Gastric Mucosa Observed Under Endoscopy in Collagenous Gastritis

Clinical Case Reports, Volume 14, Issue 4, April 2026.
ABSTRACT Collagenous gastritis (CG) is an uncommon disorder of the digestive system, characterized by marked thickening of the subepithelial collagen band and infiltration of inflammatory cells within the lamina propria. The etiology and pathogenesis of CG remain not fully understood, and its diagnosis is contingent upon histopathological evaluation ...
Qian Luo, Yujie Li, Jiemin Liu, Xiaoyuan Lin, Sainan Zhou   +4 more
wiley   +1 more source